K-H Lee - AI Profile | 人才画像

基本信息

浏览量：62

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 164 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

99P Circulating Tumor DNA As a Biomarker for Neratinib and Trastuzumab Efficacy in HER2-mutated Advanced Solid Tumors: Insights from KCSG AL20-17/KM23 Phase II Trial

K. Lee,K-H. Lee,D-W. Kim, J.S. Yoon, W. Choi, Y. Lee, Y.J. Choi, S. Lee, J.W. Kim, H. Ryu,D-H. Koo, Y-G. Lee,H-C. Jeung, M-Y. Lee, N. Lee, M.J. Kang, J. Lee, S-H. Hong,E.J. Kang, I.H. Park

Annals of Oncology (2024)

引用0浏览0引用

1324MO CNS Outcomes of Lazertinib Vs Gefitinib in EGFR-mutated Advanced NSCLC: A LASER301 Subset Analysis

R.A. Soo,B.C. Cho,J-H. Kim,M-J. Ahn,K.H. Lee, A. Zimina,S. Orlov,I. Bondarenko,Y-G. Lee, L. Yueh Ni,S.S. Lee,Y.K. Pang,C.H. Fong,J.H. Kang,C.S. Lim,P. Danchaivijitr,H. Lee, S. Park,I. Cicin

Annals of Oncology (2023): S764-S765

引用0浏览0引用

1348P Management of Paresthesia in Patients Treated with Lazertinib: Integrated Analysis of LASER201 and LASER301 Studies

Y-G. Lee, J. S. Ahn,M-J. Ahn,J. H. Kang,R. A. Soo,T. Reungwetwattana,J. C-H. Yang,I. Cicin,D-W. Kim,B. Zaric,H. Go, K. C. Jahng,S. Kim,Y. Lim,K. H. Lee,B. C. Cho

Annals of oncology（2023）

引用0浏览0引用

16P Terminally Exhausted CD8+ T Cells and Increased Immunosuppressive Soluble Factors in Malignant Ascites of Patients with Gastric Cancer with Peritoneal Metastasis

H.S. Han, H. Kim, M. Kwon,S.K. Lee,S-M. Son, H.K. Kim,Y. Yang,K.H. Lee

Annals of oncology（2023）

引用0浏览0引用

1675P Diagnostic Performance of Blood-Based DNA Methylation Assay Using Epigenetic-Specific Peptide Nucleic Acid in Pancreatic Adenocarcinoma

H. Kim, J. Chu, I-G. Do,H. K. Kim,Y. Yang,K. H. Lee, H. S. Han

Annals of Oncology (2023): S919-S919

引用0浏览0引用

814P Clinical Significance of Isolated Pulmonary Recurrence in Patients with Endometrioid Endometrial Cancer Who Achieved Complete Remission after Primary Treatment

J. Yoo,S. Lee,S. I. Kim, I. S. Hwang,J. Choi,K. H. Lee

Annals of Oncology（2023）

引用0浏览0引用

41P Efficacy of First-Line (1L) Nivolumab (N) + Ipilimumab (I) by Tumor Histologic Subtype in Patients (pts) with Metastatic Nonsquamous NSCLC (Mnsq-Nsclc)

H. Borghaei,D. Balli,L. Paz-Ares,M. Reck,S. S. Ramalingam,J. R. Brahmer,T-E. Ciuleanu,A. Pluzanski,J-S. Lee,J. Gainor,M. Schenker,A. Schoenfeld,R. Bernabe Caro,N. Ready,K. H. Lee,B. Zurawski,C. Audigier-Valette,V. Baxi, W. Geese,K. J. O'Byrne

Journal of Thoracic Oncologyno. 4 (2023): S64-S65

引用0浏览0引用

597Tip A Phase I/II Study to Evaluate the Safety and Anti-Tumor Activity of JIN-A02 in Patients with EGFR TKI-refractory, EGFR-mutant Advanced NSCLC

S.M. Lim,B.C. Cho,J-Y. Han,S-W. Kim,K.H. Lee,M. Nagasaka, T.R. Baisamut,A. Jo,E. Seah, C. Kim,S-H.I. Ou

Annals of Oncology (2023)

引用0浏览0引用

2081P the Therapeutic Effect of Anti-Inflammatory Tripeptide Cream on Hand-Foot Syndrome Related to Anticancer Drugs: A Prospective, Randomized, Placebo-Controlled Pilot Trial

Y. Yang,J-H. Han,M. S. Kim, H. Kim, H. K. Kim,K. H. Lee,H. S. Han

Annals of Oncology (2023): S1095-S1095

引用0浏览0引用

187P Phase I/II study of the oral CCR4 antagonist, FLX475, as monotherapy and in combination with pembrolizumab in advanced cancer

C-C. Lin, T.M. Kim, P. Desai,K.H. Lee,Y-H. Feng,N. Ngamphaiboon,S-B. Kim,M-H. Yang,J. Muzaffar,B. Chmielowski,P.L. Swiecicki,S.E. Bowyer,J.R. Brahmer,M. Chisamore, R. Goyal, N. Nasrah, W. Ho,B.C. Cho

Immuno-Oncology and Technology (2022): 100299-100299

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn